BioArctic AB (LTS:0RV2) FFO


LTS:0RV2 BioArctic AB LTS:0RV2
76 GF Score
Price kr308.40
GF Value kr467.59
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is BioArctic AB FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0RV2
76GF Score
BioArctic AB LTS:0RV2
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (LTS:0RV2) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of kr308.40 is trading 34% below its estimated GF Value™ of kr467.59. GuruFocus considers BioArctic AB to be Significantly Undervalued.

Key valuation signals for LTS:0RV2:

  • FFO:
  • GF Value™: kr467.59 vs. price of kr308.40 (34% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RV2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
76GF Score

Get the complete analysis for LTS:0RV2

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr308.40
Price
kr467.59
GF Value